215 related articles for article (PubMed ID: 21899916)
1. Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: effect of statins on let-7i and Toll-like receptor 4 signal.
Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
Immunobiology; 2012 May; 217(5):533-9. PubMed ID: 21899916
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.
Tabuchi T; Satoh M; Itoh T; Nakamura M
Clin Sci (Lond); 2012 Aug; 123(3):161-71. PubMed ID: 22364258
[TBL] [Abstract][Full Text] [Related]
3. Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels.
Takahashi Y; Satoh M; Minami Y; Tabuchi T; Itoh T; Nakamura M
Clin Sci (Lond); 2010 Jul; 119(9):395-405. PubMed ID: 20524934
[TBL] [Abstract][Full Text] [Related]
4. NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin.
Satoh M; Tabuchi T; Itoh T; Nakamura M
Clin Sci (Lond); 2014 Feb; 126(3):233-41. PubMed ID: 23944632
[TBL] [Abstract][Full Text] [Related]
5. Circulating Toll-like receptor 4-responsive microRNA panel in patients with coronary artery disease: results from prospective and randomized study of treatment with renin-angiotensin system blockade.
Satoh M; Takahashi Y; Tabuchi T; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
Clin Sci (Lond); 2015 Apr; 128(8):483-91. PubMed ID: 25385173
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin decreases Toll-like receptor 4 expression and downstream signaling in human monocytic leukemia cells.
Yang SS; Li R; Qu X; Fang W; Quan Z
Cell Immunol; 2012 Sep; 279(1):96-102. PubMed ID: 23103560
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors.
Waehre T; Yndestad A; Smith C; Haug T; Tunheim SH; Gullestad L; Frøland SS; Semb AG; Aukrust P; Damås JK
Circulation; 2004 Apr; 109(16):1966-72. PubMed ID: 15051633
[TBL] [Abstract][Full Text] [Related]
8. Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease.
Minami Y; Satoh M; Maesawa C; Takahashi Y; Tabuchi T; Itoh T; Nakamura M
Eur J Clin Invest; 2009 May; 39(5):359-67. PubMed ID: 19371267
[TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin combined with regular exercise preserves coenzyme Q10 levels associated with a significant increase in high-density lipoprotein cholesterol in patients with coronary artery disease.
Toyama K; Sugiyama S; Oka H; Iwasaki Y; Sumida H; Tanaka T; Tayama S; Jinnouchi H; Matsui K; Ogawa H
Atherosclerosis; 2011 Jul; 217(1):158-64. PubMed ID: 21458815
[TBL] [Abstract][Full Text] [Related]
10. A cellular microRNA, let-7i, is a novel biomarker for clinical outcome in patients with dilated cardiomyopathy.
Satoh M; Minami Y; Takahashi Y; Tabuchi T; Nakamura M
J Card Fail; 2011 Nov; 17(11):923-9. PubMed ID: 22041329
[TBL] [Abstract][Full Text] [Related]
11. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
12. Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease.
Waehre T; Damås JK; Gullestad L; Holm AM; Pedersen TR; Arnesen KE; Torsvik H; Frøland SS; Semb AG; Aukrust P
J Am Coll Cardiol; 2003 May; 41(9):1460-7. PubMed ID: 12742282
[TBL] [Abstract][Full Text] [Related]
13. Effects of switching statins on lipid and apolipoprotein ratios in the MERCURY I study.
Cheung RC; Morrell JM; Kallend D; Watkins C; Schuster H
Int J Cardiol; 2005 Apr; 100(2):309-16. PubMed ID: 15823640
[TBL] [Abstract][Full Text] [Related]
14. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease--a randomized, placebo-controlled study.
Alber HF; Frick M; Suessenbacher A; Doerler J; Schirmer M; Stocker EM; Dichtl W; Pachinger O; Weidinger F
Am Heart J; 2006 Jan; 151(1):139. PubMed ID: 16368305
[TBL] [Abstract][Full Text] [Related]
15. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
Fonseca FA; Ruiz A; Cardona-Muñoz EG; Silva JM; Fuenmayor N; Marotti M;
Curr Med Res Opin; 2005 Aug; 21(8):1307-15. PubMed ID: 16083541
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 4 expressions on peripheral blood monocytes were enhanced in coronary artery disease even in patients with low C-reactive protein.
Shiraki R; Inoue N; Kobayashi S; Ejiri J; Otsui K; Honjo T; Takahashi M; Hirata K; Yokoyama M; Kawashima S
Life Sci; 2006 Dec; 80(1):59-66. PubMed ID: 17045300
[TBL] [Abstract][Full Text] [Related]
17. High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins.
Smith C; Halvorsen B; Otterdal K; Waehre T; Yndestad A; Fevang B; Sandberg WJ; Breland UM; Frøland SS; Oie E; Gullestad L; Damås JK; Aukrust P
Cardiovasc Res; 2008 Jul; 79(1):195-203. PubMed ID: 18339644
[TBL] [Abstract][Full Text] [Related]
18. Effect of atorvastatin on in vitro expression of resistin in adipocytes and monocytes/macrophages and effect of atorvastatin treatment on serum resistin levels in patients with type 2 diabetes.
Ichida Y; Hasegawa G; Fukui M; Obayashi H; Ohta M; Fujinami A; Ohta K; Nakano K; Yoshikawa T; Nakamura N
Pharmacology; 2006; 76(1):34-9. PubMed ID: 16227702
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin affects TLR4 clustering via lipid raft modulation.
Chansrichavala P; Chantharaksri U; Sritara P; Ngaosuwankul N; Chaiyaroj SC
Int Immunopharmacol; 2010 Aug; 10(8):892-9. PubMed ID: 20472098
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of Toll like receptor 4 on peripheral-blood mononuclear cells in patients with coronary arteriosclerosis disease.
Geng HL; Lu HQ; Zhang LZ; Zhang H; Zhou L; Wang H; Zhong RQ
Clin Exp Immunol; 2006 Feb; 143(2):269-73. PubMed ID: 16412050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
